Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541648
PUBLISHER: IMARC | PRODUCT CODE: 1541648
Vaccine Contract Manufacturing Market Report by Vaccine Type (Attenuated, Inactivated, Subunit-based, Toxoid-based, DNA-based), Workflow (Downstream, Upstream), Application (Human Use, Veterinary), and Region 2024-2032
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global vaccine contract manufacturing market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.8% during 2024-2032.
Vaccine contract manufacturing refers to the outsourcing of large-scale production of vaccines to contract manufacturing organizations (CMOs). These organizations offer numerous services, including pre-formulation work, formulation development, method development, stability studies, pre-clinical activities, registration batches and commercial manufacturing. Apart from this, they provide expertise and innovative technologies to expand the production chain of pharmaceutical companies. At present, the demand for outsourcing vaccine manufacturing activities is escalating worldwide on account of reduced development costs and complex production protocols.
Vaccination plays a pivotal role in improving human as well as veterinary health. It reduces the need for antibiotics and prevents diseases. The increasing awareness about vaccination and numerous associated benefits, such as protection from severe illnesses and infectious diseases, is catalyzing the demand for immunization programs and inoculations. This, in confluence with understanding the complexity of capital requirement for production, has led the leading pharmaceutical companies to outsource vaccine manufacturing. Apart from this, the lack of equipment and skilled labor for vaccine production in low-resource countries is also contributing to the global vaccine contract manufacturing market growth. Moreover, technological advancements, including the introduction of expression systems like the EB66 and GPEx and cell culture media platforms, are supporting the market growth. Furthermore, the alarmingly growing cases of coronavirus disease (COVID-19) in numerous countries have propelled the vaccine developers to sign outsourcing agreements with CMOs. This is creating a favorable outlook for the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine contract manufacturing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, workflow and application.
Breakup by Vaccine Type:
Attenuated
Inactivated
Subunit-based
Toxoid-based
DNA-based
Breakup by Workflow:
Downstream
Fill and Finish Operations
Analytical and QC Studies
Packaging
Upstream
Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Baculovirus/Insect Expression Systems
Others
Breakup by Application:
Human Use
Veterinary
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Co. Inc., Albany Molecular Research Inc, Catalent Inc, Cobra Biologics Limited (Charles River Laboratories International Inc.), Cytovance Biologics Inc. (Hepalink USA Inc.), Fujifilm Holdings Corporation, ICON plc, IDT Biologika GmbH, Lonza Group AG, Merck KGaA, Pharmaceutical Product Development LLC and PRA Health Sciences Inc.
Key Questions Answered in This Report:
- How has the global vaccine contract manufacturing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global vaccine contract manufacturing market?
- What are the key regional markets?
- What is the breakup of the market based on the vaccine type?
- What is the breakup of the market based on the workflow?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global vaccine contract manufacturing market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A3872
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Vaccine Contract Manufacturing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Vaccine Type
- 6.1 Attenuated
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Inactivated
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Subunit-based
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Toxoid-based
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 DNA-based
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Workflow
- 7.1 Downstream
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Fill and Finish Operations
- 7.1.2.2 Analytical and QC studies
- 7.1.2.3 Packaging
- 7.1.3 Market Forecast
- 7.2 Upstream
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Mammalian Expression Systems
- 7.2.2.2 Bacterial Expression Systems
- 7.2.2.3 Yeast Expression Systems
- 7.2.2.4 Baculovirus/Insect Expression Systems
- 7.2.2.5 Others
- 7.2.3 Market Forecast
8 Market Breakup by Application
- 8.1 Human Use
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Veterinary
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Ajinomoto Co. Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Albany Molecular Research Inc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Catalent Inc
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Cobra Biologics Limited (Charles River Laboratories International Inc.)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Cytovance Biologics Inc. (Hepalink USA Inc.)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Fujifilm Holdings Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 ICON plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 IDT Biologika GmbH
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Lonza Group AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Merck KGaA
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Pharmaceutical Product Development LLC
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 PRA Health Sciences Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.1 Ajinomoto Co. Inc.
Product Code: SR112024A3872
List of Figures
- Figure 1: Global: Vaccine Contract Manufacturing Market: Major Drivers and Challenges
- Figure 2: Global: Vaccine Contract Manufacturing Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Vaccine Contract Manufacturing Market: Breakup by Vaccine Type (in %), 2023
- Figure 5: Global: Vaccine Contract Manufacturing Market: Breakup by Workflow (in %), 2023
- Figure 6: Global: Vaccine Contract Manufacturing Market: Breakup by Application (in %), 2023
- Figure 7: Global: Vaccine Contract Manufacturing Market: Breakup by Region (in %), 2023
- Figure 8: Global: Vaccine Contract Manufacturing (Attenuated) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Vaccine Contract Manufacturing (Attenuated) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Vaccine Contract Manufacturing (Inactivated) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Vaccine Contract Manufacturing (Inactivated) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Vaccine Contract Manufacturing (Subunit-based) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Vaccine Contract Manufacturing (Subunit-based) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Vaccine Contract Manufacturing (Toxoid-based) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Vaccine Contract Manufacturing (Toxoid-based) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Vaccine Contract Manufacturing (DNA-based) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Vaccine Contract Manufacturing (DNA-based) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Vaccine Contract Manufacturing (Downstream) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Vaccine Contract Manufacturing (Downstream) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Vaccine Contract Manufacturing (Upstream) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Vaccine Contract Manufacturing (Upstream) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Vaccine Contract Manufacturing (Human Use) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Vaccine Contract Manufacturing (Human Use) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Vaccine Contract Manufacturing (Veterinary) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Vaccine Contract Manufacturing (Veterinary) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: North America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: North America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: United States: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: United States: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Canada: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Canada: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Asia-Pacific: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Asia-Pacific: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: China: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: China: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Japan: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Japan: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: India: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: India: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: South Korea: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: South Korea: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Australia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Australia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Indonesia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Indonesia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Europe: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Europe: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Germany: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Germany: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: France: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: France: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: United Kingdom: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: United Kingdom: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Italy: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Italy: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Spain: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Spain: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Russia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Russia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Latin America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Latin America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Brazil: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Brazil: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Mexico: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Mexico: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Middle East and Africa: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Middle East and Africa: Vaccine Contract Manufacturing Market: Breakup by Country (in %), 2023
- Figure 74: Middle East and Africa: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Global: Vaccine Contract Manufacturing Industry: SWOT Analysis
- Figure 76: Global: Vaccine Contract Manufacturing Industry: Value Chain Analysis
- Figure 77: Global: Vaccine Contract Manufacturing Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Vaccine Contract Manufacturing Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
- Table 3: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Workflow (in Million US$), 2024-2032
- Table 4: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Vaccine Contract Manufacturing Market: Competitive Structure
- Table 7: Global: Vaccine Contract Manufacturing Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.